Merceditas Villanueva, MD
Associate Professor of Medicine (AIDS); HIV / AIDS Care Program Director, Infectious Diseases; Donaldson Firm Chief, Infectious Diseases
Research & Publications
Biography
News
Locations
Coauthors
Selected Publications
- Improving HIV and HCV Testing in Substance Use Disorder Programs (SUDs) That Provide Medications for Opiate Use Disorder (MOUD): Role of Addressing Barriers and Implementing Universal and Site-Specific ApproachesBrooks R, Wegener M, Freeman B, Fowles C, Madden L, Tetrault J, Nichols L, Altice F, Villanueva M. Improving HIV and HCV Testing in Substance Use Disorder Programs (SUDs) That Provide Medications for Opiate Use Disorder (MOUD): Role of Addressing Barriers and Implementing Universal and Site-Specific Approaches. Health Promotion Practice 2023, 24: 1018-1028. PMID: 37439759, DOI: 10.1177/15248399231169791.
- Expanded or Risk Factor-Based Annual Screening for Hepatitis C Virus (HCV) Among Persons With HIV: Which Is the Best Approach?Hao R, Brooks R, Zelenev A, Spinner G, Barakat L, Villanueva M. Expanded or Risk Factor-Based Annual Screening for Hepatitis C Virus (HCV) Among Persons With HIV: Which Is the Best Approach? Health Promotion Practice 2023, 24: 1009-1017. PMID: 37439817, DOI: 10.1177/15248399231169794.
- The Cooperative Re-Engagement Controlled Trial (CoRECT): Durable Viral Suppression AssessmentO'Shea J, Fanfair R, Williams T, Khalil G, Brady K, DeMaria A, Villanueva M, Randall L, Jenkins H, Altice F, Camp N, Lucas C, Buchelli M, Samandari T, Weidle P. The Cooperative Re-Engagement Controlled Trial (CoRECT): Durable Viral Suppression Assessment. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2023, 93: 134-142. PMID: 36812382, PMCID: PMC10962216, DOI: 10.1097/qai.0000000000003178.
- Implementing a Surveillance-Based Approach to Create a Statewide Viral Clearance Cascade for Hepatitis C Among People With HIV and HCV Coinfection in ConnecticutWegener M, Brooks R, Speers S, Nichols L, Villanueva M. Implementing a Surveillance-Based Approach to Create a Statewide Viral Clearance Cascade for Hepatitis C Among People With HIV and HCV Coinfection in Connecticut. Public Health Reports 2023, 139: 208-217. PMID: 37232422, PMCID: PMC10851907, DOI: 10.1177/00333549231172173.
- Costs and cost‐effectiveness of a collaborative data‐to‐care intervention for HIV treatment and care in the United StatesShrestha R, Fanfair R, Randall L, Lucas C, Nichols L, Camp N, Brady K, Jenkins H, Altice F, DeMaria A, Villanueva M, Weidle P. Costs and cost‐effectiveness of a collaborative data‐to‐care intervention for HIV treatment and care in the United States. Journal Of The International AIDS Society 2023, 26: e26040. PMID: 36682053, PMCID: PMC9867888, DOI: 10.1002/jia2.26040.
- Implementing a Surveillance-Based Approach to Create a Statewide Viral Clearance Cascade for Hepatitis C Among People with HIV and HCV Coinfection in ConnecticutWegener M, Brooks R, Speers S, Nichols L, Villanueva M
- The Cooperative Re-Engagement Controlled Trial (CoRECT): Durable Viral Suppression AssessmentO’Shea J, Neblett Fanfair R, Williams T, Khalil G, Brady K, DeMaria A, Villanueva M, Randall L, Jenkins H, Altice F, Camp N, Lucas C, Buchelli M, Samandari T, Weidle P
- Costs and cost-effectiveness of a collaborative data to care intervention for HIV prevention in the USShrestha RK, Neblett Fanfair R, Randall L, Lucas C, Nichols L, Camp N, Brady K, Jenkins H, Altice F, Villanueva M, Demaria A
- Correction to: Experiences with Telemedicine for HIV Care During the COVID-19 Pandemic: A Mixed-Methods StudyHarsono D, Deng Y, Chung S, Barakat LA, Friedland G, Meyer JP, Porter E, Villanueva M, Wolf MS, Yager JE, Edelman EJ. Correction to: Experiences with Telemedicine for HIV Care During the COVID-19 Pandemic: A Mixed-Methods Study. AIDS And Behavior 2022, 27: 2054-2054. PMID: 36318433, PMCID: PMC9628372, DOI: 10.1007/s10461-022-03907-y.
- Perceptions Towards HCV Treatment with Direct Acting Antivirals (DAAs): A Qualitative Analysis with Persons with HIV/HCV Co-infection Who Delay or Refuse TreatmentBrothers S, DiDomizio E, Nichols L, Brooks R, Villanueva M. Perceptions Towards HCV Treatment with Direct Acting Antivirals (DAAs): A Qualitative Analysis with Persons with HIV/HCV Co-infection Who Delay or Refuse Treatment. AIDS And Behavior 2022, 27: 119-133. PMID: 35776253, PMCID: PMC9663279, DOI: 10.1007/s10461-022-03749-8.
- Advancing data to care strategies for persons with HIV using an innovative reconciliation processVillanueva M, Miceli J, Speers S, Nichols L, Carroll C, Jenkins H, Altice F. Advancing data to care strategies for persons with HIV using an innovative reconciliation process. PLOS ONE 2022, 17: e0267903. PMID: 35511958, PMCID: PMC9071117, DOI: 10.1371/journal.pone.0267903.
- Longitudinal Improvements in Viral Suppression for Persons With New HIV Diagnosis Receiving Care in the Ryan White Program: A 10-Year Experience in New Haven, CT (2009–2018)Zhao A, Rizk C, Zhao X, Esu A, Deng Y, Barakat L, Villanueva M. Longitudinal Improvements in Viral Suppression for Persons With New HIV Diagnosis Receiving Care in the Ryan White Program: A 10-Year Experience in New Haven, CT (2009–2018). Open Forum Infectious Diseases 2022, 9: ofac196. PMID: 35794946, PMCID: PMC9251657, DOI: 10.1093/ofid/ofac196.
- Rapidly enlarging pulmonary mass due to immune reconstitution inflammatory syndrome (IRIS) in an immunocompetent host with pulmonary Cryptococcus neoformans.Tucker M, Sheikh AM, Villanueva MS. Rapidly enlarging pulmonary mass due to immune reconstitution inflammatory syndrome (IRIS) in an immunocompetent host with pulmonary Cryptococcus neoformans. BMJ Case Reports 2022, 15: e247495. PMID: 35351746, PMCID: PMC8966528, DOI: 10.1136/bcr-2021-247495.
- Methadone Referrals DemystifiedSims K, Brooks R, Nichols L, Wegener M, Villanueva M. Methadone Referrals Demystified. 2022, 217-237. DOI: 10.4018/978-1-7998-9490-2.ch010.
- Experiences with Telemedicine for HIV Care During the COVID-19 Pandemic: A Mixed-Methods StudyHarsono D, Deng Y, Chung S, Barakat LA, Friedland G, Meyer JP, Porter E, Villanueva M, Wolf MS, Yager JE, Edelman EJ. Experiences with Telemedicine for HIV Care During the COVID-19 Pandemic: A Mixed-Methods Study. AIDS And Behavior 2022, 26: 2099-2111. PMID: 35064390, PMCID: PMC8782707, DOI: 10.1007/s10461-021-03556-7.
- Yale New Haven Hospital Donaldson Firm Curriculum. An Educational Guide for Donaldson Monthly Rotationhttps://medicine.yale.edu/intmed/hivtraining/donaldson/curriculum/
- Methadone Referrals Demystified: A Client's Journey Into Methadone Treatment – Social Constructivism and the Use of Video-Based Content in Medical Provider EducationSims, K. M., Brooks, R., Nichols, L., Wegener, M. D., & Villanueva, M. S. (2022). Methadone Referrals Demystified: A Client's Journey Into Methadone Treatment – Social Constructivism and the Use of Video-Based Content in Medical Provider Education. In S. Tamim (Ed.), Instructional Design Exemplars in eHealth and mHealth Education Interventions (pp. 217-237). IGI Global. https://doi.org/10.4018/978-1-7998-9490-2.ch010
- Treatment of Hepatitis C virus among people who inject drugs at a syringe service program during the COVID-19 response: The potential role of telehealth, medications for opioid use disorder and minimal demands on patientsSivakumar A, Madden L, DiDomizio E, Eller A, Villanueva M, Altice FL. Treatment of Hepatitis C virus among people who inject drugs at a syringe service program during the COVID-19 response: The potential role of telehealth, medications for opioid use disorder and minimal demands on patients. International Journal Of Drug Policy 2021, 101: 103570. PMID: 34954493, PMCID: PMC8685180, DOI: 10.1016/j.drugpo.2021.103570.
- 843. Targeted HIV Testing for Patients Hospitalized for COVID-19Virata M, Villanueva M, Miceli J. 843. Targeted HIV Testing for Patients Hospitalized for COVID-19. Open Forum Infectious Diseases 2021, 8: 512-512. PMCID: PMC8643876, DOI: 10.1093/ofid/ofab466.1038.
- Cumulative burden of non-communicable diseases predicts COVID hospitalization among people with HIV: A one-year retrospective cohort studyVirata MD, Shenoi SV, Ladines-Lim J, Villanueva MS, Barakat LA. Cumulative burden of non-communicable diseases predicts COVID hospitalization among people with HIV: A one-year retrospective cohort study. PLOS ONE 2021, 16: e0260251. PMID: 34851963, PMCID: PMC8635326, DOI: 10.1371/journal.pone.0260251.
- The Cooperative Re-Engagement Controlled trial (CoRECT): A randomised trial to assess a collaborative data to care model to improve HIV care continuum outcomesFanfair R, Khalil G, Williams T, Brady K, DeMaria A, Villanueva M, Randall L, Jenkins H, Altice F, Camp N, Lucas C, Buchelli M, Samandari T, Weidle P. The Cooperative Re-Engagement Controlled trial (CoRECT): A randomised trial to assess a collaborative data to care model to improve HIV care continuum outcomes. The Lancet Regional Health - Americas 2021, 3: 100057. PMID: 36777404, PMCID: PMC9903939, DOI: 10.1016/j.lana.2021.100057.
- National Landscape of Human Immunodeficiency Virus-Positive Deceased Organ Donors in the United States.Werbel WA, Brown DM, Kusemiju OT, Doby BL, Seaman SM, Redd AD, Eby Y, Fernandez RE, Desai NM, Miller J, Bismut GA, Kirby CS, Schmidt HA, Clarke WA, Seisa M, Petropoulos CJ, Quinn TC, Florman SS, Huprikar S, Rana MM, Friedman-Moraco RJ, Mehta AK, Stock PG, Price JC, Stosor V, Mehta SG, Gilbert AJ, Elias N, Morris MI, Mehta SA, Small CB, Haidar G, Malinis M, Husson JS, Pereira MR, Gupta G, Hand J, Kirchner VA, Agarwal A, Aslam S, Blumberg EA, Wolfe CR, Myer K, Wood RP, Neidlinger N, Strell S, Shuck M, Wilkins H, Wadsworth M, Motter JD, Odim J, Segev DL, Durand CM, Tobian AAR, Piquant D, Link K, Hemmersbach-Miller M, Pearson T, Turgeon N, Lyon G, Kitchens W, Huckaby J, Lasseter A, Elbein R, Roberson A, Ferry E, Klock E, Cochran W, Morrison M, Rasmussen S, Bollinger J, Sugarman J, Smith A, Thomas M, Coakley M, Timpone J, Stucke A, Haydel B, Dieter R, Klein E, Neumann H, Gallon L, Goudy L, Callegari M, Marrazzo I, Jackson T, Pruett T, Farnsworth M, Locke J, Mompoint-Williams D, Basinger K, Mekeel K, Nguyen P, Kwan J, Srisengfa T, Chin-Hong P, Rogers R, Simkins J, Munoz C, Dunn T, Sawinski D, Silveira F, Hughes K, Pakstis D, Nagy J, Baldecchi M, Muthukumar T, Eddie M, Robb K, Salsgiver E, Witting B, Azar M, Villanueva M, Formica R, Tomlin R. National Landscape of Human Immunodeficiency Virus-Positive Deceased Organ Donors in the United States. Clinical Infectious Diseases 2021, 74: 2010-2019. PMID: 34453519, PMCID: PMC9187316, DOI: 10.1093/cid/ciab743.
- Clinical characteristics and outcomes for 7,995 patients with SARS-CoV-2 infectionMcPadden J, Warner F, Young HP, Hurley NC, Pulk RA, Singh A, Durant TJS, Gong G, Desai N, Haimovich A, Taylor RA, Gunel M, Dela Cruz CS, Farhadian SF, Siner J, Villanueva M, Churchwell K, Hsiao A, Torre CJ, Velazquez EJ, Herbst RS, Iwasaki A, Ko AI, Mortazavi BJ, Krumholz HM, Schulz WL. Clinical characteristics and outcomes for 7,995 patients with SARS-CoV-2 infection. PLOS ONE 2021, 16: e0243291. PMID: 33788846, PMCID: PMC8011821, DOI: 10.1371/journal.pone.0243291.
- The Yale department of Medicine COVID-19 Data Explorer and repository (DOM-CCovX): An innovative approach to promoting collaborative scholarship during a pandemicArora T, Simonov M, Alausa J, Subair L, Gerber B, Nguyen A, Hsiao A, Hintz R, Yamamoto Y, Soufer R, Desir G, Wilson F, Villanueva M. The Yale department of Medicine COVID-19 Data Explorer and repository (DOM-CCovX): An innovative approach to promoting collaborative scholarship during a pandemic. medRxiv, Aug 26, 2021
- The Cooperative Re-Engagement Controlled trial (CoRECT): A randomised trial to assess a collaborative data to care model to improve HIV care continuum outcomesNeblett Fanfair, Robyn, Khalil, George,, Williams,Tiffany, Brady, Kathleen , DeMaria, Alfred, Villanueva, Merceditas, Randall, Liisa M, Jenkins, Heidi, Altice, Frederick L., Camp, Nasima, Lucas, Crystal, Buchelli, Marianne, Samandari, Taraz, Weidle, Paul J. The Cooperative Re-engagement Controlled Trial: A Randomized Trial to Assess a Collaborative Data to Care Model to Improve HIV Care Continuum Outcomes. The Lancet Regional Health-Americas, August 28,2021.
- 957. Efficacy of Using Disease Intervention Specialists (DIS) to Re-engage Out of Care HIV/HCV Co-Infected Persons into HCV TreatmentWegener M, Brooks R, Speers S, Gosselin D, Villanueva M. 957. Efficacy of Using Disease Intervention Specialists (DIS) to Re-engage Out of Care HIV/HCV Co-Infected Persons into HCV Treatment. Open Forum Infectious Diseases 2020, 7: s509-s510. PMCID: PMC7777068, DOI: 10.1093/ofid/ofaa439.1143.
- 933. Cured vs. Not Yet Treated: Population Differences for HIV/HCV Co-infected Patients Navigating the HCV Care Cascade in 11 Connecticut ClinicsBrooks R, Wegener M, Speers S, Sideleau R, Nichols L, Villanueva M. 933. Cured vs. Not Yet Treated: Population Differences for HIV/HCV Co-infected Patients Navigating the HCV Care Cascade in 11 Connecticut Clinics. Open Forum Infectious Diseases 2020, 7: s500-s500. PMCID: PMC7777100, DOI: 10.1093/ofid/ofaa439.1119.
- 932. Creating a Statewide HCV Treatment Cascade for HIV/HCV Co-Infected Persons Using a Partnership with DPHWegener M, Brooks R, Speers S, Villanueva M. 932. Creating a Statewide HCV Treatment Cascade for HIV/HCV Co-Infected Persons Using a Partnership with DPH. Open Forum Infectious Diseases 2020, 7: s499-s500. PMCID: PMC7776146, DOI: 10.1093/ofid/ofaa439.1118.
- 961. Implementing an HIV Ambulatory Curriculum in Internal Medicine Residency ProgramsAoun-Barakat L, McKay S, Danvers K, Sideleau R, Brooks R, Villanueva M. 961. Implementing an HIV Ambulatory Curriculum in Internal Medicine Residency Programs. Open Forum Infectious Diseases 2020, 7: s511-s511. PMCID: PMC7776830, DOI: 10.1093/ofid/ofaa439.1147.
- 111. Outcomes Related to COVID-19 Among People Living with HIV: Cohort from a Large Academic CenterVirata M, Shenoi S, Ladines-Lim J, Villanueva M, Aoun-Barakat L. 111. Outcomes Related to COVID-19 Among People Living with HIV: Cohort from a Large Academic Center. Open Forum Infectious Diseases 2020, 7: s184-s184. PMCID: PMC7777957, DOI: 10.1093/ofid/ofaa439.421.
- 543. SARS-CoV-2 Viral Dynamics For Symptomatic People Living with HIV Requiring Hospitalization For COVID-19Virata M, Villanueva M, Shenoi S, Ladines-Lim J, Aoun-Barakat L. 543. SARS-CoV-2 Viral Dynamics For Symptomatic People Living with HIV Requiring Hospitalization For COVID-19. Open Forum Infectious Diseases 2020, 7: s338-s338. PMCID: PMC7777445, DOI: 10.1093/ofid/ofaa439.737.
- Tocilizumab Treatment for Cytokine Release Syndrome in Hospitalized Patients With Coronavirus Disease 2019 Survival and Clinical OutcomesPrice CC, Altice FL, Shyr Y, Koff A, Pischel L, Goshua G, Azar MM, Mcmanus D, Chen SC, Gleeson SE, Britto CJ, Azmy V, Kaman K, Gaston DC, Davis M, Burrello T, Harris Z, Villanueva MS, Aoun-Barakat L, Kang I, Seropian S, Chupp G, Bucala R, Kaminski N, Lee AI, LoRusso PM, Topal JE, Dela Cruz C, Malinis M. Tocilizumab Treatment for Cytokine Release Syndrome in Hospitalized Patients With Coronavirus Disease 2019 Survival and Clinical Outcomes. CHEST Journal 2020, 158: 1397-1408. PMID: 32553536, PMCID: PMC7831876, DOI: 10.1016/j.chest.2020.06.006.
- Confronting Another Pandemic: Lessons from HIV can Inform Our COVID-19 ResponseEdelman EJ, Aoun-Barakat L, Villanueva M, Friedland G. Confronting Another Pandemic: Lessons from HIV can Inform Our COVID-19 Response. AIDS And Behavior 2020, 24: 1977-1979. PMID: 32399798, PMCID: PMC7215127, DOI: 10.1007/s10461-020-02908-z.
- A Colocalized Hepatitis C Virus Clinic in a Primary Care Practice Improves Linkage to Care in a High Prevalence PopulationAdamson PC, Miceli J, Shiferaw B, Villanueva MS, Canterino JE. A Colocalized Hepatitis C Virus Clinic in a Primary Care Practice Improves Linkage to Care in a High Prevalence Population. The American Journal Of Medicine 2020, 133: 705-712. PMID: 31987799, DOI: 10.1016/j.amjmed.2019.12.028.
- AETC website; including Project CONNQuer, content and training videoshttps://aetcct.org
- Project ConnQuER Hep C:Connecticut Quantification, Evaluation and Response: HIV/HCV Elimination in Persons of Colorhttps://aetcct.org/connquer-hepc/
- 1311. Ryan White HIV Care Continuum Model Doubled the Rate of Community HIV Viral Suppression for Newly Diagnosed Patients: A 10-Year ReviewRizk C, Zhao A, Miceli J, Shea P, Villanueva M, Barakat L. 1311. Ryan White HIV Care Continuum Model Doubled the Rate of Community HIV Viral Suppression for Newly Diagnosed Patients: A 10-Year Review. Open Forum Infectious Diseases 2019, 6: s473-s473. PMCID: PMC6808875, DOI: 10.1093/ofid/ofz360.1174.
- Implementing Data to Care-What Are the Costs for the Health Department?Neblett Fanfair R, Shrestha RK, Randall L, Lucas C, Nichols L, Camp NM, Brady K, Jenkins H, Altice F, Villanueva M, DeMaria A. Implementing Data to Care-What Are the Costs for the Health Department? JAIDS Journal Of Acquired Immune Deficiency Syndromes 2019, 82 Suppl 1: s57-s61. PMID: 31425397, DOI: 10.1097/qai.0000000000001968.
- Implementing a Comprehensive HCV Clinic within an HIV Clinic: A Model of Care for HCV Micro-eliminationRizk C, Miceli J, Shiferaw B, Malinis M, Barakat L, Ogbuagu O, Villanueva M. Implementing a Comprehensive HCV Clinic within an HIV Clinic: A Model of Care for HCV Micro-elimination. Open Forum Infectious Diseases 2019, 6: ofz361. PMID: 31412130, PMCID: PMC6785669, DOI: 10.1093/ofid/ofz361.
- Integration of care for HIV and opioid use disorderOldfield B, Muñoz N, McGovern M, Funaro M, Villanueva M, Tetrault J, Edelman E. Integration of care for HIV and opioid use disorder. AIDS 2019, Publish Ahead of Print: &na;. PMID: 30882491, PMCID: PMC6588508, DOI: 10.1097/qad.0000000000002125.
- 2234. Implementing a Co-located HCV Clinic Within an HIV Clinic: Four Year ExperienceVillanueva M, Rizk C, Shiferaw B, Ogbuagu O, Malinis M, Miceli J. 2234. Implementing a Co-located HCV Clinic Within an HIV Clinic: Four Year Experience. Open Forum Infectious Diseases 2018, 5: s660-s661. PMCID: PMC6252933, DOI: 10.1093/ofid/ofy210.1887.
- “No more falling through the cracks”: A qualitative study to inform measurement of integration of care of HIV and opioid use disorderOldfield BJ, Muñoz N, Boshnack N, Leavitt R, McGovern MP, Villanueva M, Tetrault JM, Edelman E. “No more falling through the cracks”: A qualitative study to inform measurement of integration of care of HIV and opioid use disorder. Journal Of Substance Use And Addiction Treatment 2018, 97: 28-40. PMID: 30577897, DOI: 10.1016/j.jsat.2018.11.007.
- A rare case of visceral leishmaniasis in an immunocompetent traveler returning to the United States from EuropeHaque L, Villanueva M, Russo A, Yuan Y, Lee EJ, Topal J, Podoltsev N. A rare case of visceral leishmaniasis in an immunocompetent traveler returning to the United States from Europe. PLOS Neglected Tropical Diseases 2018, 12: e0006727. PMID: 30286207, PMCID: PMC6171829, DOI: 10.1371/journal.pntd.0006727.
- Paradoxical Reaction in a Patient with Co-Occurring Tuberculous Meningitis and Pott’s DiseaseRobledo-Gil T, Harada K, Ikuta I, Villanueva M. Paradoxical Reaction in a Patient with Co-Occurring Tuberculous Meningitis and Pott’s Disease. American Journal Of Case Reports 2018, 19: 699-704. PMID: 29907737, PMCID: PMC6034555, DOI: 10.12659/ajcr.909194.
- Fatal cryptococcal meningitis in an AIDS patient complicated with immune reconstitution syndrome refractory to prolonged amphotericin B treatmentBandaranayake TD, Ogbuagu OE, Mahajan A, Vortmeyer AO, Villanueva MS. Fatal cryptococcal meningitis in an AIDS patient complicated with immune reconstitution syndrome refractory to prolonged amphotericin B treatment. International Journal Of STD & AIDS 2018, 29: 1250-1254. PMID: 29749873, DOI: 10.1177/0956462418773219.
- The Natural History and Predictors of Liver Fibrosis Progression Using the FIB-4 Score Among HIV/HCV Co-infected Adults in an Outpatient Clinic in the USAYuh B, Kyriakides T, Ogbuagu O, Villanueva M. The Natural History and Predictors of Liver Fibrosis Progression Using the FIB-4 Score Among HIV/HCV Co-infected Adults in an Outpatient Clinic in the USA. Open Forum Infectious Diseases 2017, 4: s658-s659. DOI: 10.1093/ofid/ofx163.1753.
- Efficacy of an 8-week course of sofosbuvir and ledipasvir for the treatment of HCV infection in selected HIV-infected patientsOgbuagu O, Hao R, Virata M, Villanueva M, Malinis M. Efficacy of an 8-week course of sofosbuvir and ledipasvir for the treatment of HCV infection in selected HIV-infected patients. F1000Research 2017, 6: 620. DOI: 10.12688/f1000research.11397.1.
- Responding to an Ever-Changing Epidemic: The History of HIV/AIDS Care in New HavenVillanueva MS and Friedland G. Responding to an Ever-Changing Epidemic: The History of HIV/AIDS Care in New Haven. CT Medicine 2017; 81(4): 237-40
- The Natural History of FIB-4 Score Progression Among HIV/Hepatitis C Virus (HCV)–Coinfected Adults in an Outpatient ClinicYuh B, Ogbuagu O, Villanueva M. The Natural History of FIB-4 Score Progression Among HIV/Hepatitis C Virus (HCV)–Coinfected Adults in an Outpatient Clinic. Open Forum Infectious Diseases 2016, 3: 2147. DOI: 10.1093/ofid/ofw172.1695.
- Integrase strand transferase inhibitors: the preferred antiretroviral regimen in HIV-positive renal transplantationAzar MM, Malinis MF, Moss J, Formica RN, Villanueva MS. Integrase strand transferase inhibitors: the preferred antiretroviral regimen in HIV-positive renal transplantation. International Journal Of STD & AIDS 2016, 28: 447-458. PMID: 27193421, DOI: 10.1177/0956462416651528.
- Meningitis Caused by Candida Dubliniensis in a Patient with Cirrhosis: A Case Report and Review of the LiteratureYamahiro A, Lau KH, Peaper DR, Villanueva M. Meningitis Caused by Candida Dubliniensis in a Patient with Cirrhosis: A Case Report and Review of the Literature. Mycopathologia 2016, 181: 589-593. PMID: 27038312, DOI: 10.1007/s11046-016-0006-7.
- Trends in Tuberculosis Cases at a Connecticut Hospital, 2005–2014Yuh T, Ogbuagu O, Villanueva M, Shenoi S. Trends in Tuberculosis Cases at a Connecticut Hospital, 2005–2014. Open Forum Infectious Diseases 2015, 2: 566. DOI: 10.1093/ofid/ofv133.440.
- Su1395 Eligibility of a Real World Population for Phase 3 Clinical Trials for Chronic Hepatitis C InfectionAngulo-Diaz V, Sadigh K, Ogbuagu O, Sarkar S, Villanueva M, Lim J. Su1395 Eligibility of a Real World Population for Phase 3 Clinical Trials for Chronic Hepatitis C Infection. Gastroenterology 2015, 148: s-496-s-497. DOI: 10.1016/s0016-5085(15)31666-8.
- Trends in Tuberculosis Cases at a Connecticut Hospital, 2005–2014Yuh T, Ogbuagu O, Villanueva M, Shenoi S. Trends in tuberculosis cases at a Connecticut Hospital 2005-2014. Open Forum Infectious Diseases 2015; (2) suppl 1), December 2015, 566 https://doi.org/10.1093/ofid/ofv133.440
- MHC class I antigen processing of Listeria monocytogenes proteins: implications for dominant and subdominant CTL responses.Pamer EG, Sijts AJ, Villanueva MS, Busch DH, Vijh S. MHC class I antigen processing of Listeria monocytogenes proteins: implications for dominant and subdominant CTL responses. Immunological Reviews 1997, 158: 129-36. PMID: 9314081, DOI: 10.1111/j.1600-065x.1997.tb00999.x.
- CTL epitope generation is tightly linked to cellular proteolysis of a Listeria monocytogenes antigen.Sijts AJ, Villanueva MS, Pamer EG. CTL epitope generation is tightly linked to cellular proteolysis of a Listeria monocytogenes antigen. Journal Of Immunology (Baltimore, Md. : 1950) 1996, 156: 1497-503. PMID: 8568253.
- Listeriolysin is processed efficiently into an MHC class I-associated epitope in Listeria monocytogenes-infected cells.Villanueva MS, Sijts AJ, Pamer EG. Listeriolysin is processed efficiently into an MHC class I-associated epitope in Listeria monocytogenes-infected cells. Journal Of Immunology (Baltimore, Md. : 1950) 1995, 155: 5227-33. PMID: 7594534.
- Infection with Listeria monocytogenes impairs sialic acid addition to host cell glycoproteins.Villanueva MS, Beckers CJ, Pamer EG. Infection with Listeria monocytogenes impairs sialic acid addition to host cell glycoproteins. The Journal Of Experimental Medicine 1994, 180: 2137-45. PMID: 7964488, PMCID: PMC2191782, DOI: 10.1084/jem.180.6.2137.
- Efficiency of MHC class I antigen processing: a quantitative analysis.Villanueva MS, Fischer P, Feen K, Pamer EG. Efficiency of MHC class I antigen processing: a quantitative analysis. Immunity 1994, 1: 479-89. PMID: 7534616, DOI: 10.1016/1074-7613(94)90090-6.
Clinical Trials
Conditions | Study Title |
---|---|
HIV/AIDS | Kidney Transplantation in Recipients and Donors with HIV: Long Term Follow up Study |
Diseases of the Kidney & Urinary Tract; HIV/AIDS | HOPE in Action Prospective Multicenter, Clinical Trial of Deceased HIVD+ Kidney Transplants for HIV+ Recipients |